Taro announces merger agreement with Sun Pharma
Agreed Price of US$43 per share to deliver 48% premium to unaffected price on May 25, 2023
Agreed Price of US$43 per share to deliver 48% premium to unaffected price on May 25, 2023
The bold, dynamic, and new logo unveiled in this process captures the essence of the 'Better Together' theme
Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa
The launch will enable PCC to further expand their existing Zinc Sulfate Injection product line and overall the generic injectables portfolio
Microdosing has emerged as a key trend in the pharmaceutical and nutritional markets
PharmaLogic will assist ARTBIO with radiochemistry and supply of the finished radiopharmaceutical product for future Phase I and II clinical trials of AB001 from their facility in New York
The R&D centre is mainly dedicated to the Process R&D of New Chemical Entities (NCE) development projects
He is also inducted as a member of the management council and senior management personnel of the company
Tornado will enhance Bruker’s biopharma PAT portfolio with its well-established products
Subscribe To Our Newsletter & Stay Updated